Detailed Product Description

  Exelon (rivastigmine tartrate) is a cholinesterase inhibitor. The exact mechanism of rivastigmine's action is unknown, however it is thought to exert its therapeutic effect by enhancing cholinergic function. It inhibits the cholinesterase enzyme from breaking down acetylcholine, increasing both the level and duration of action of the neurotransmitter acetylcholine.

Exelon is specifically indicated for the treatment of mild to moderate dementia of the Alzheimers type and for the treatment of mild to moderate dementia associated with Parkinsons disease.

 

Rivastigmine tartrate

CAS: [ 129101-54-8 ]

(s)-n-ethyl-3-[(1-dimethylamino)ethyl]-n-methylphenylcarbamate hydrogen tartrate

Molecular formula: C14H22N2O2. C4H6O6FW 400.42

Appearance: white crystalline powder

Quality standard:Company standard

Uses:cretinism drug

Packing: 5kg/can, 10kg/drum

Storage: Sealed, in dark place

Rivastigmine Hydrogen Tartrate /
CAS No: 129101-54-8
Appearance: white or almost white powder
Loss on drying: Max1. 0%
Single impurity: Max0. 5%
Total impurities: Max 1. 0%
Assay: Min99. 0%